MDB — Medicofarma Biotech SA Cashflow Statement
0.000.00%
- PLN17.40m
- PLN17.40m
- PLN1.22m
Annual cashflow statement for Medicofarma Biotech SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.916 | -0.215 | -1.59 | -3.44 | -2.3 |
Depreciation | |||||
Non-Cash Items | 0.116 | -0.054 | — | 0.166 | 0.12 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.45 | 1.13 | 0.801 | 1.29 | -0.388 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -0.312 | 1.82 | 0.96 | 0.007 | -1.02 |
Capital Expenditures | — | -2.3 | -1.21 | -1.11 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.342 | -13.7 | — | — | 0 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.342 | -16 | -1.21 | -1.11 | 0 |
Financing Cash Flow Items | -0.3 | -0.012 | -0.007 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.066 | 14.2 | 0.678 | 0.597 | 1.02 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.036 | 0.053 | 0.43 | -0.502 | 0.001 |